How GLP-1 Drugs Are Reshaping Fashion Runways and Fabrics

Bullet bras, corsets, sheer organza and cinched waists filled the Spring/Summer 2027 runways, and the trend is prompting a bigger question: are weight loss drugs changing how fashion dresses? GLP-1 sales reached $79 billion in 2025, according to Morgan Stanley Research. A Consumer Goods Forum and Bain & Co. report expects one in three Americans to use the drugs by 2030.

Shrinking Clients, Shifting Production

Paris-based luxury personal shopper Isabel Bazzani says couture houses have had to update client records because stored measurements no longer fit. She adds that luxury labels are producing fewer large sizes and more small ones. Analysts urge caution, however. Heuritech’s Frida Tordhag says her data shows no straight correlation, while EDITED’s Krista Corrigan sees hints of influence but admits proof is difficult.

Functionality may be the clearest link. WGSN’s Laura Yiannakou says around 40% of consumers using such medications prioritise comfort because of bloating and temperature shifts. Designers responded with adjustable details, from lacing at Miu Miu to Velcro fastenings at Prada, plus statement belts at Celine and Valentino. EDITED data shows arrivals of adjustable-waistband bottoms more than doubled month-on-month in May 2026.

Sheer, Soft and Inclusive

Rather than tighter clothing, Heuritech reports bodycon dress arrivals falling 8% in Europe, while fine lace is up 41% in China. Bra tops appeared at Prada, Miu Miu and Hermès, putting waists and arms on show.

Yet the link is far from simple. Ester Manas and Di Petsa showed sheer, body-conscious designs on diverse bodies, and Rick Owens and Collina Strada also kept inclusivity central. Together they suggest skin-baring fashion is not reserved for one body type.